This website uses text-to-speech software called Browsealoud to read and / or translate its content . To use Browsealoud, you must allow Browsealoud cookies; the Browsealoud icon will then appear at the bottom right of your screen.
You can find out more about how Browsealoud uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow Browsealoud cookies Do not use Browsealoud
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Patients and visitors must wear a face covering in our hospitals.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
The James Lind Alliance (JLA) is a non-profit making initiative. Its aim is to bring patients, carers, family members and healthcare professionals together to identify and prioritise research questions for researchers and funders to address. The JLA oversees all partnerships, like this one, which prioritise research questions.
From 1 April 2013, the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) has coordinated the work of the JLA.
To affiliate to the JLA or to find out more please contact the James Lind Alliance.
The Early Osteoarthritis of Hip and Knee Priority Setting Partnership is funded by:
In addition, the NIHR Oxford Biomedical Research Centre (BRC) is providing co-ordination through the James Lind Alliance PSP hub.
The wider partnership includes: